Stimulated salivary flow rate and composition in asthmatic and non- asthmatic adults

Archives of Oral Biology

Volumn 43, Issue 2, 1998, Pages 151-156

  Lenander Lumikari, M ^a   Laurikainen, K ^d   Kuusisto, P ^b   Vilja, P ^c  

^a UNIVERSITY OF TURKU   (Finland)

^b TAMPERE UNIVERSITY HOSPITAL   (Finland)

^c TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^d NONE

Author keywords

Asthma; Saliva composition; Salivary flow rate

Indexed keywords

CALCIUM; LACTOFERRIN; LYSOZYME; MYELOPEROXIDASE; PEROXIDASE; POTASSIUM; SALIVA PROTEIN; SODIUM; THIOCYANATE; THIOCYANIC ACID DERIVATIVE;

ADULT; ANAEROBIC BACTERIUM; ARTICLE; ASTHMA; BACTERIAL COUNT; BACTERIAL FLORA; CANDIDA; CELL STIMULATION; CHEMISTRY; COMPARATIVE STUDY; DENTAL CARIES; ENZYME ACTIVATION; FEMALE; GROWTH, DEVELOPMENT AND AGING; HEALTH SURVEY; HUMAN; LACTOBACILLUS; MAJOR CLINICAL STUDY; MALE; METABOLISM; MICROBIOLOGY; PATHOPHYSIOLOGY; PERIODONTICS; PERIODONTITIS; SALIVA; SALIVA ANALYSIS; SALIVATION; SECRETION; STATISTICS; STREPTOCOCCUS MUTANS;

ADULT; ASTHMA; BACTERIA, ANAEROBIC; CALCIUM; CANDIDA; COLONY COUNT, MICROBIAL; CONFIDENCE INTERVALS; DMF INDEX; FEMALE; HUMANS; LACTOBACILLUS; LACTOFERRIN; MALE; MIDDLE AGED; MURAMIDASE; PERIODONTAL INDEX; PERIODONTITIS; PEROXIDASE; PEROXIDASES; POTASSIUM; SALIVA; SALIVARY PROTEINS; SECRETORY RATE; SODIUM; STREPTOCOCCUS MUTANS; THIOCYANATES;

BACTERIA (MICROORGANISMS); CANDIDA; LACTOBACILLUS; STREPTOCOCCUS MUTANS;

EID: 0344878847     PISSN: 00039969     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-9969(97)00110-6     Document Type: Article

References (39)

1. Bakkenist A. R. J., Wever R., Vulsma T., Plat H., van Gelder B. F. Isolation procedure and some properties of myeloperoxidase from human leukocytes. Biochim. Biophys. Acta. 524:1978;45-54.
2. Barka T., Yagil C., van der Noen H., Naito Y. Induction of the synthesis of a specific protein in rat submandibular gland by isoprotetenol. Lab. Invest. 54:1986;165-171.
3. Ben-Aryeh H., Berdicevsky I., Zinmann P., Szargel R., Alroy G., Gutman D. Salivary composition and oral candida in asthmatic children and the effect of inhaled drugs. J. oral Med. 40:1985;123-126.
4. Betts R. H., Dainton F. S. Electron transfer and other processes involved in the spontaneous bleaching of acidified solutions of ferric thiocyanate. J. Am. Chem. Soc. 75:1953;5721-5727.
5. Bjerkeborn K., Dahllöf G., Hedlin G., Lindell M., Modéer T. Effect of disease severity and pharmacotherapy of asthma on oral health in asthmatic children. Scand. J. dent. Res. 95:1987;159-164.
6. Brill N., Krasse B. The passage of tissue fluid into the clinically healthy gingival pocket. Acta Odontol. Scand. 16:1958;233-245.
7. Cao C. F., Smith Q. T. Crevicular fluid myeloperoxidase at healthy, gingivitis and periodontitis sites. J. Clin. Periodontol. 16:1989;17-20.
8. Herrera J. L., Lyons I. I. M. F., Johnson L. F. Saliva: its role in health and disease. J. Clin. Gastroenterol. 10:1988;569-578.
9. Hyyppä T., Paunio K. Oral health and salivary factors in children with asthma. Proc. Finn. Dent. Soc. 75:1979;7-10.
10. Hyyppä T. M., Koivikko A., Paunio K. U. Studies on periodontal conditions in asthmatic children. Acta Odontol. Scand. 37:1979;15-20.
11. Jensen J. L., Brodin P., Berg T., Aars H. Parotid secretion of fluid, amylase and kallikrein during reflex stimulation under normal condition and after acute administration of autonomic blocking agents in man. Acta Physiol. Scand. 143:1991;321-328.
12. Johansson I., Ericson T. Saliva composition and caries development during protein deficiency and β-receptor stimulation or inhibition. J. Oral Pathol. 16:1987;145-149.
13. Karhuvaara L., Tenovuo J., Sievers G. Crevicular fluid myeloperoxidase - an indicator of acute gingival inflammation. Proc. Finn. Dent. Soc. 86:1990;3-8.
14. Laurikainen K., Laurikainen E., Tenovuo J., Kaila T., Vilja P. Effects of a β-blocking agent, timolol maleate, on saliva in healthy volunteers. Scand. J. dent. Res. 96:1988;121-127.
15. Lowry O. H., Rosebrough N. J., Farr A. L., Randall R. J. Protein measurement with the folin phenol reagent. J. Biol. Chem. 193:1951;265-275.
16. Mandel I. D. The functions of saliva. J. dent. Res. 66:1987;623-627.
17. Mandel I. D., Zengo A., Katz R., Wotman S. Effects of adrenergic agents on salivary composition. J. dent. Res. 54:1975;27-33.
18. Månsson-Rahemtulla B., Rahemtulla F., Baldone D. C., Pruitt K. M., Hjerpe A. Purification and characterization of human salivary peroxidase. Biochemistry. 27:1988;233-239.
19. Närhi T. O., Ainamo A., Meurman J. H. Salivary yeasts, saliva and oral mucosa in the elderly. J. dent Res. 72:1993;1009-1014.
20. Navazesh M., Wood G. J., Brightman V. Relationship between salivary flow rates and Candida albicans counts. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 80:1995;284-288.
21. Nederfors T., Ericsson T., Twetman S., Dahlöf C. Effects of the β-adrenoceptor antagonists atenolol and propranolol on human parotid and submandibular-sublingual salivary secretion. J. dent Res. 73:1994;5-10.
22. 1-selective antagonist metoprolol in a hypertensive patient population. Eur. J. oral Sci. 104:1996;262-268.
23. Papas A. S., Joshi A., MacDonald S. L., Maravelis-Spagounais L., Pretara-Spanedda P., Curro F. A. Caries prevalence in xerostomic individuals. J. Can. Dent. Assoc. 59:1993;171-179.
24. Parvinen T., Parvinen I., Larmas M. Stimulated salivary flow rate, pH, and lactobacillus and yeast concentrations in medicated persons. Scand. J. dent. Res. 92:1984;524-532.
25. 2-adrenoceptor agonists on saliva protein and dental caries in asthmatic children. J. dent Res. 66:1987;1404-1406.
26. Ryberg M., Johansson I., Mörnstad H., Ericson T. Effect of long-term isoproterenol treatment on caries development in the rat using a low-cariogenic model. Caries Res. 22:1988;297-301.
27. Ryberg M., Johansson I., Ericson T., Mörnstad H., Henriksson R., Jönsson G., Sundström S. Effects of chronic stimulation of salivary gland β-adrenoceptors on saliva composition and caries development in the rat. J. Oral Pathol. Med. 18:1989;529-532.
28. 2-adrenoceptor agonists. Archs oral Biol. 35:1990;945-948.
29. 2-adrenoceptor agonists: a 4-year follow-up study. Scand. J. dent. Res. 99:1991;212-218.
30. Salzman G. A., Pyszczynski D. R. Oropharyngeal cadidiasis in patients treated with beclomethasone diproprionate delivered by meter-dose inhaler alone and with Aerochamber. J. Allergy Clin. Immunol. 81:1988;424-428.
31. Shaw N. J., Edmunds A. T. Inhaled beclomethasone and oral candidiasis. Arch. Dis. Child. 61:1986;788-790.
32. Steckfus C. F., Wu A. J., Ship J. A., Brown L. J. Comparison of stimulated parotid salivary gland flow rates in normotensive and hypertensive persons. Oral Surg. Oral Med. Oral Pathol. 77:1994;615-619.
33. Storhaug K. Caries experience in disabled pre-school children. Acta Odontol. Scand. 43:1985;241-248.
34. Thomas E. L., Jefferson M. M., Joyner R. E., Cook G. S., King C. C. Leukocyte myeloperoxidase and salivary lactoperoxidase: Identification and quantitation in human mixed saliva. J. dent. Res. 73:1994;544-555.
35. Toogood J. H., White F. A., Baskerville J. C., Fraher L. J., Jennings B. Comparison of the asthmatic oropharyngeal and systemic glucocorticoid effects of budesonide administrated through a pressurized aerosol plus spacer or the Turbuhaler dry powder inhaler. J. Allergy Clin. Immuno. 99:1997;186-193.
36. Vilja P., Krohn K., Tuohimaa P. A rapid and sensitive non-competitive avidin-biotin assay for lactoferrin. J. Immunol. Meth. 76:1985;73-83.
37. Vilja P., Lumikari M., Tenovuo J., Sievers G., Tuohimaa P. Sensitive immunometric assays for secretory peroxidase and myeloperoxidase in human saliva. J. Immunol. Meth. 141:1991;277-284.
38. World Health Organisation Guidelines (1987) Oral Health Surveys. In Basic methods. WHO, Geneva.
39. Wright D. E. The source and rate of entry of leucocytes in the human mouth. Archs Oral Biol. 9:1964;321-329.